Characteristics, healthcare utilization, and outcomes of patients with HER2-low breast cancer. Check DK, Jackson BE, Reeder-Hayes KE, Dinan MA, et al. Breast Cancer Res Treat 2023 Oct 24. doi: 10.1007/s10549-023-07142.

Read + Share

Amedeo Smart

Independent Medical Education

Check DK, Jackson BE, Reeder-Hayes KE, Dinan MA, et al. Characteristics, healthcare utilization, and outcomes of patients with HER2-low breast cancer. Breast Cancer Res Treat 2023 Oct 24. doi: 10.1007/s10549-023-07142.
PMID: 37875669